Skip to main content

You are here

NICORETTE® dual support

References

  1. Cahill K, Stevens S et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;5: CD009329
  2. Zhou X, Nonnemaker J et al. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav 2009;34:365-373
  3. Imperial Cancer Research Fund General Practice Research Group. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. BMJ 1993;306:1304-1308
  4. Richmond R L, Harris K, de Almeida Neto A. The transdermal nicotine patch: results of a randomised placebo-controlled trial. Med J Aust 1994;161:130-135
  5. Tonnesen P, Paoletti P et al. Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 1999;13:238-246
  6. Sachs D P, Sawe U, Leischow S J. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med 1993;153:1881-1890
  7. Russell M A, Stapleton J A et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ 1993;306:1308-1312
  8. National Institute for Health and Care Excellence (NICE) Public Health Guidance 45 (PH45) Smoking: harm reduction. June 2013 revised in July 2013
  9. National Institute for Health and Care Excellence (NICE) Public Health Guidance 10 (PH10) Stop smoking services. February 2008 revised in November 2013
  10. National Health Service (NHS) Employers. Quality and outcomes framework for 2012/13. Guidance for PCOs and Practices. Available at: www.myhealth.london.nhs.uk (link is external). Accessed January 2018
  11. Stead L F, Perera R et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146
  12. Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. JAMA 2014;311:193-194
  13. McRobbie H, McEwan A. Helping smokers to stop: advice for pharmacists in England. NICE. Royal Pharmaceutical Society of Great Britain and Pharmacy/HealthLink. 2005
  14. Van Gucht D, Van den Bergh O et al. Smoking behavior in context: where and when do people smoke? J Behav Ther Exp Psychiatry 2010;41:172-177
  15. Hansson A, Hajek P et al. Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial. BMJ Open2012;2
  16. Nicorette Inhalator Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/24853. Johnson & Johnson Limited. Accessed: December 2017
  17. Nicorette QuickMist 1mg/spray mouthspray Summary of Product Characteristics. Johnson & Johnson Limited. Available at: https://www.medicines.org.uk/emc/medicine/24257. Accessed December 2017
  18. Nicorette Lozenge Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/26492. Johnson & Johnson Limited. Accessed: December 2017
  19. Nicorette Nasal Spray Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20679. Johnson & Johnson Limited. Accessed: December 2017
  20. Nicorette Microtab Summary of Product Characteristics. Johnson & Johnson Limited. Available at: https://www.medicines.org.uk/emc/medicine/20534. Accessed: December 2017
  21. Nicotine Addiction in Britain. A report of the Tobacco Advisory Group of The Royal College of Physicians. 2000

Resources

View a range of Johnson & Johnson Ltd developed materials to support patients on their journey to stop smoking.

NICORETTE® products

Learn more about the range of NICORETTE® nicotine replacement products and which ones are most suited to your patients.